Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Value Trial Group

    Research output: Contribution to journalArticleScientificpeer-review

    182 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)403-411
    JournalJournal of Hypertension
    Volume26
    Issue number3
    Publication statusPublished - 2008
    Publication typeA1 Journal article-refereed

    Cite this